Results 231 to 240 of about 346,610 (333)

The Feasibility and Quality of the European Prescribing Exam: An International Multicenter Pilot Study Among 3109 Medical Students From 16 Medical Schools

Clinical Pharmacology &Therapeutics, EarlyView.
The WHO Global Patient Safety Challenge “Medication Without Harm” emphasizes the need to improve doctors' prescribing competence. Junior doctors are particularly at risk of prescribing errors due to inadequate training. To address this, the European Prescribing Exam was developed to standardize and improve clinical pharmacology and therapeutics (CPT ...
Erik M. Donker, Joost D. Piët, David J. Brinkman, Milan C. Richir, Paraskevi Papaioannidou, Robert Likic, Emilio J. Sanz, Thierry Christiaens, João N. Costa, Fabrizio De Ponti, Ylva Böttiger, Cornelis Kramers, Michiel A. van Agtmael, Jelle Tichelaar, on behalf of the Erasmus+ consortium EuroPE+ and the EACPT Education Working Group, Emilio Sanz, Carla Sans, Ellen van Leeuwen, Haithem Chtioui, Joao Costa, Jitka Rychlickova, Lorena Dima, Romaldas Maciulaitis, Marc Labriffe, Bogdan Tamba, Michiel van Agtmael, Erik Donker   +26 more
wiley   +1 more source

Extrahepatic Portal Vein Occlusion and Collateral Formation Following Anticoagulant-Induced Thrombosis Regression in a Portal Vein Aneurysm: Potential for Misdiagnosis As Primary Extrahepatic Portal Vein Occlusion. [PDF]

Cureus
Okano H, Tsuruga S, Mukai K, Nishimura A.   +3 more
europepmc   +1 more source

Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation [PDF]

, 2001
Calatzis, A., Schiffl, Helmut, Schramm, W., Spannagl, M., Toepfer, Marcel   +4 more
core   +1 more source

Assessment of Short-term Anticoagulant Administration after Cardiac Infarction [PDF]

, 1969

openalex   +1 more source

Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance is a critical component of medication safety. Despite rigorous evaluation of new drugs during clinical trials, some adverse effects might only be identified once pharmaceuticals are used by a larger population for a longer duration.
Claire Spahn, Nanase Toda, Blaine Groat, Omar Aimer, Sara Rogers, Akinyemi Oni‐Orisan, Andrew Monte, Nancy Hakooz, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +8 more
wiley   +1 more source

Interplay Between Sickle Cell Disease and Thrombosis: A Single Center Experience of Pathophysiology and Potential Risk Factors. [PDF]

Hematol Rep
Tzanninis R, Vlachaki E, Lefkou E, Tsiara S, Theodoridou S, Vyzantiadis A, Matsagkas M.   +6 more
europepmc   +1 more source

On the nature of anticoagulant action of rare-earth metals

, 1953
Jun Sato
openalex   +2 more sources

Cerebrovascular Disease: Trial of Long-term Anticoagulant Therapy [PDF]

, 1962
A. Bradford Hill, John Marshall, D.A. Shaw   +2 more
openalex   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin. [PDF]

J Enzyme Inhib Med Chem
Ge P, Jin M, Li Z, Zhu L.
europepmc   +1 more source